Similarly, using different canine osteosarcoma cell lines as an in vitro model, it has been demonstrated that MDR1 is a molecular mechanism related to resistance to the topoisomerase inhibitor etoposide, a member of a promising class of chemotherapeutic agents [37]. This evidence concerns the gene ABCB1 and osteosarcoma.